EUVIMEDEUVIMED entdecken
Crossref

Variation in anti-SARS-CoV-2 spike antibody responses by variants in patients with severe mental illness after COVID-19 vaccination

Chun-Yuan Lin, Ying-Chyi Song, Chin-Chou Yang, Po-Shou Yeh, Ya-Yen Yu, Chih-Chia Huang

Brain, Behavior, and Immunity · 2025

DOI: 10.1016/j.bbi.2025.06.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025. Verfasst von Chun-Yuan Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan; Program in Translational Medicine, National Chung Hsing University, Taich…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Antibodies, Viral. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Research has shown that patients with psychiatric disorders are more susceptible to contracting SARS-CoV-2 and tend to experience worse outcomes from COVID-19. Therefore, vaccination is strongly suggested for these patients to enhance protection. However, there is limited research on how COVID-19 vaccines induce antibody responses, specifically in individuals with psychiatric conditions. Furthermore, the situation has become more complex with the emergence of variants of concern (VOCs), and the effectiveness of antibody responses against these variants is still poorly understood. To determine whether patients with severe mental illness (SMI) mount an adequate immune reaction to COVID-19 vaccination, we studied the immunization effect of two widely used vaccines, ChAdOx1-S (AstraZeneca) and mRNA-1273 (Moderna), in patients with SMI compared to healthy controls. We enrolled 163 patients with SMI (mainly schizophrenia) and 66 healthy controls, all of whom were negative for previous SARS-CoV-2 infection. We analyzed anti-SARS-CoV-2 spike antibody titers against wild-type (WT), Delta, and Omicron variants after full (two-dose) vaccination with either the ChAdOx1-S or mRNA-1273 COVID-19 vaccines. Patients with SMI exhibited significantly lower mean anti-SARS-CoV-2 spike antibody titers. These results were consistent across different vaccine types and VOCs. Vaccination with ChAdOx1-S consistently induced lower spike-binding antibodies against WT, Delta, and Omicron variants compared to the mRNA-1273 vaccine. While the antibody activities against Omicron are well preserved, they are weaker than those against the WT and Delta variants. Our findings explain why patients with SMI are particularly susceptible to SARS-CoV-2 infection, breakthrough infections, and poorer COVID-19 outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, ViralCOVID-19 VaccinesMental DisordersHumansMaleFemaleMiddle AgedAdultChAdOx1 nCoV-192019-nCoV Vaccine mRNA-1273VaccinationAntibody FormationSchizophreniaAged

Stichwörter der Autor:innen

Anti-SARS-CoV-2 spike antibodyCOVID-19SARS-CoV-2Severe mental illnessesVariants of concern

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, ViralCOVID-19 VaccinesChAdOx1 nCoV-19spike protein, SARS-CoV-22019-nCoV Vaccine mRNA-1273

Autor:innen und Institutionen

  • Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan; Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan; National Changhua University of Education, Changhua, Taiw…
  • Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan; Research Center of Tradit…
  • Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan; Department of Nursing, Hungkuang University, Taichung, Taiwan; College of Agriculture and Health, Tunghai University, Taichung, Taiwan; Departm…
  • Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan.
  • Chang-Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan.
  • Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan; Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan. Electronic address: chihchiahuang@yahoo.com.tw.

Zitieren

APA

Lin, C. Y., Song, Y. C., Yang, C. C., Yeh, P. S., Yu, Y. Y., & Huang, C. C. (2025). Variation in anti-SARS-CoV-2 spike antibody responses by variants in patients with severe mental illness after COVID-19 vaccination. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2025.06.015

Vancouver

Lin CY, Song YC, Yang CC, Yeh PS, Yu YY, Huang CC. Variation in anti-SARS-CoV-2 spike antibody responses by variants in patients with severe mental illness after COVID-19 vaccination. Brain, Behavior, and Immunity. 2025. doi:10.1016/j.bbi.2025.06.015

BibTeX
@article{Lin2025,
  author = {Lin, Chun-Yuan and Song, Ying-Chyi and Yang, Chin-Chou and Yeh, Po-Shou and Yu, Ya-Yen and Huang, Chih-Chia},
  title = {Variation in anti-SARS-CoV-2 spike antibody responses by variants in patients with severe mental illness after COVID-19 vaccination},
  journal = {Brain, Behavior, and Immunity},
  year = {2025},
  doi = {10.1016/j.bbi.2025.06.015}
}
Kostenlos starten →